Neonc Technologies, Inc.
Clinical trials sponsored by Neonc Technologies, Inc., explained in plain language.
-
Experimental brain cancer drug shows promise in early trial
Disease control Recruiting nowThis study tests an experimental drug called NEO100 (perillyl alcohol) in people with recurrent or worsening grade III or IV gliomas that have an IDH1 mutation. The goal is to find a safe dose and see if it helps patients live longer. Participants take the drug four times daily i…
Phase: PHASE1, PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 26, 2026 10:54 UTC
-
New hope for tough brain tumors? drug trial targets meningioma that Won't quit
Disease control Recruiting nowThis study tests a drug called NEO100 in people with a fast-growing type of brain tumor (high-grade meningioma) that remains after surgery or has come back. About 30 participants will take NEO100 four times a day in 28-day cycles. The goal is to see if the drug can stop the tumor…
Phase: PHASE2 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated May 26, 2026 10:48 UTC